Quantitative analysis of expression level of BCL2 and BAX genes in Hep-2 and HL-60 cells after treatment with etoposide

Acta Medica (Hradec Kralove). 2008;51(3):191-5. doi: 10.14712/18059694.2017.23.

Abstract

Apoptotic cell death is a highly regulated process, which plays a crucial role in many biological events. The aim of the present research was to investigate the expression of the apoptosis related genes BCL2 and BAX in Hep-2 and HL60 cells. Apoptosis was induced in these cell lines during treatment with etoposide. The expression levels of BCL2 and BAX genes were measured after 6 h and 12 h of treatment by quantitative real-time RT-PCR. In Hep-2 cells the expression level of BCL2 significantly increased both 6 h and 12 h of treatment, whereas expression level of BAX didn't change. In HL-60 cells the expression level of BCL2 decreased after 6 h of treatment and expression of BAX increased both 6 h and 12 h of treatment with etoposide. Those findings show distinct reactions of Hep-2 and HL-60 cells to etoposide treatment and different upregulation or downregulation of apoptosis-related genes BCL2 and BAX.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents, Phytogenic / pharmacology*
  • Apoptosis / drug effects
  • Apoptosis / genetics
  • Cell Line, Tumor
  • Etoposide / pharmacology*
  • Gene Expression Regulation, Neoplastic / drug effects*
  • Genes, bcl-2 / genetics*
  • HL-60 Cells
  • Humans
  • Reverse Transcriptase Polymerase Chain Reaction
  • bcl-2-Associated X Protein / genetics*

Substances

  • Antineoplastic Agents, Phytogenic
  • bcl-2-Associated X Protein
  • Etoposide